Joint Modeling in Detecting Predictors of CD4 Cell Count and Status of Tuberculosis Among People Living with HIV/AIDS Under HAART at Felege Hiwot Teaching and Specialized Hospital, North-West Ethiopia

被引:6
作者
Bayabil, Setegn [1 ]
Seyoum, Awoke [2 ]
机构
[1] Debre Tabor Univ, Dept Stat, Debre Tabor, Ethiopia
[2] Bahir Dar Univ, Dept Stat, Bahir Dar, Ethiopia
来源
HIV AIDS-RESEARCH AND PALLIATIVE CARE | 2021年 / 13卷
关键词
CD4; cell; TB status; separate model; joint model; HAART; HIV; COINFECTION; MORTALITY; TB; EPIDEMIOLOGY; MANAGEMENT; BURDEN; COHORT; IMPACT;
D O I
10.2147/HIV.S307069
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Globally, for individuals infected with HIV, the presence of other infections including TB tends to increase the rate of HIV replication. Of the 8.8 million TB cases worldwide, an estimated 1.1 million (13%) were found to be co-infected with HIV. This research was conducted with the objective to identify potential predictors for the status of TB and CD4 cell count under PLWHIV at Felege Hiwot Specialized Hospital, North-west Ethiopia. Methods: A retrospective repeated measurement was taken from a sample of 226 HIV patients. Separate and joint models were conducted for data analysis of CD4 cell count and TB status of people living with HIV. Results: The descriptive statistics indicated that among the HIV patients receiving HAART, 26.6% had additional TB. AIDS clinical stage, weight, and hemoglobin level had a significant positive association with CD4 cell count, but a negative association with TB status. Weight and CD4 cell count have a negative relationship with the event of HIV/TB co-infection. Hence, the expected number of CD4 cell count of HIV patients who were co-infected with TB was decreased by 2.34 as compared to people living with HIV without TB. As visiting times of patients to hospitals for treatment increased by one unit, the odds of being co-infected with TB was decreased by 0.05, and the expected number of CD4 cell count was increased by 0.2. As patients' age increased by one year, the expected number of CD4 cell count was decreased by 0.025 cells per/mm(3). Conclusion: Having lower CD4 cell count, lower weight, late WHO clinical stage, being non-adherent, having opportunistic infection, having lower hemoglobin, being ambulatory and bedridden were associated with a higher risk of co-infection of HIV/TB and were indicators of progression of the disease.
引用
收藏
页码:527 / 537
页数:11
相关论文
共 25 条
  • [1] The Impact of HIV Infection and CD4 Cell Count on the Performance of an Interferon Gamma Release Assay in Patients with Pulmonary Tuberculosis
    Aabye, Martine G.
    Ravn, Pernille
    PrayGod, George
    Jeremiah, Kidola
    Mugomela, Apolinary
    Jepsen, Maria
    Faurholt, Daniel
    Range, Nyagosya
    Friis, Henrik
    Changalucha, John
    Andersen, Aase B.
    [J]. PLOS ONE, 2009, 4 (01):
  • [2] Adams M, 2013, EUR SCI J, V9
  • [3] [Anonymous], 2012, Global Tuberculosis Report
  • [4] Demissie M, 2000, ETHIOP J HEALTH DEV, V14, DOI [10.4314/ejhd.v14i3.9900, DOI 10.4314/EJHD.V14I3.9900]
  • [5] Tuberculosis and HIV co-infection: its impact on quality of life
    Deribew, Amare
    Tesfaye, Markos
    Hailmichael, Yohannes
    Negussu, Nebiyu
    Daba, Shallo
    Wogi, Ajeme
    Belachew, Tefera
    Apers, Ludwig
    Colebunders, Robert
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2009, 7
  • [6] Modelling of viral load dynamics and CD4 cell count progression in an antiretroviral naive cohort: using a joint linear mixed and multistate Markov model
    Dessie, Zelalem G.
    Zewotir, Temesgen
    Mwambi, Henry
    North, Delia
    [J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [7] Fujiwara PI, 2005, INT J TUBERC LUNG D, V9, P946
  • [8] Initiative ST World Health Organization, 2007, STOP TB PARTNERSHIP
  • [9] RELATIONSHIP OF THE MANIFESTATIONS OF TUBERCULOSIS TO CD4 CELL COUNTS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    JONES, BE
    YOUNG, SMM
    ANTONISKIS, D
    DAVIDSON, PT
    KRAMER, F
    BARNES, PF
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (05): : 1292 - 1297
  • [10] Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1
    Katlama, Christine
    Esposito, Roberto
    Gatell, Jose M.
    Goffard, Jean-Christophe
    Grinsztejn, Beatriz
    Pozniak, Anton
    Rockstroh, Jurgen
    Stoehr, Albrecht
    Vetter, Norbert
    Yeni, Patrick
    Parys, Wim
    Vangeneugdenk, Tony
    [J]. AIDS, 2007, 21 (04) : 395 - 402